Photocure ASA (OSL: PHO)

Norway flag Norway · Delayed Price · Currency is NOK
52.00
-0.80 (-1.52%)
Nov 18, 2024, 4:25 PM CET
-3.70%
Market Cap 1.34B
Revenue (ttm) 526.25M
Net Income (ttm) 14.16M
Shares Out 27.11M
EPS (ttm) 1.23
PE Ratio 40.28
Forward PE 72.29
Dividend n/a
Ex-Dividend Date n/a
Volume 26,683
Open 52.50
Previous Close 52.80
Day's Range 51.80 - 53.00
52-Week Range 47.00 - 71.90
Beta 1.00
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical p... [Read more]

Sector Healthcare
Founded 1993
Employees 102
Stock Exchange Oslo Børs
Ticker Symbol PHO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.